Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/21/21 17:00 | 12/17/21 | TYRA | Health | Drug | Pharmaceutical Preparations | Boxer Capital, LLC | CA | T | P | 1,640 | 13.12 | 0 | 125 | 2 | 6,448 | D | |||||||||||||||
9/21/21 16:03 | 9/17/21 | TYRA | Health | Drug | Pharmaceutical Preparations | Cormorant Asset Management, LP | MA | H | Former 1 | P.d | 5,000 | 16.00 | 0 | 313 | 41 | 1,070 | I | ||||||||||||||
9/17/21 16:48 | 9/17/21 | TYRA | Health | Drug | Pharmaceutical Preparations | More Robert J | CA | D | P.d | 2,500 | 16.00 | 0 | 156 | 4 | 4,080 | I | |||||||||||||||
9/17/21 16:47 | 9/17/21 | TYRA | Health | Drug | Pharmaceutical Preparations | Alta Partners Nextgen Fund II Management, LLC | WY | T | P.d | 2,500 | 16.00 | 0 | 156 | 4 | 4,080 | I | |||||||||||||||
9/17/21 16:38 | 9/17/21 | TYRA | Health | Drug | Pharmaceutical Preparations | Boxer Capital, LLC | CA | T | P.d | 10,000 | 16.00 | 0 | 625 | 288 | D | ||||||||||||||||
9/17/21 16:34 | 9/17/21 | TYRA | Health | Drug | Pharmaceutical Preparations | Ra Capital Management, L.P. | MA | DT | P.d | 20,000 | 16.00 | 0 | 1,250 | 443 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |